Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperkinetic syndromes. Therapeutic trials].

P Severini, A Pompili, G Pierini

    Rivista Di Neurologia
    |March 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A search for decays of the Higgs boson to invisible particles in events with a top-antitop quark pair or a vector boson in proton-proton collisions at <math></math>.

    The European physical journal. C, Particles and fields·2023
    Same author

    Measurement of the Dependence of the Hadron Production Fraction Ratios f_{s}/f_{u} and f_{d}/f_{u} on B Meson Kinematic Variables in Proton-Proton Collisions at sqrt[s]=13  TeV.

    Physical review letters·2023
    Same author

    Search for Exotic Higgs Boson Decays H→AA→4γ with Events Containing Two Merged Diphotons in Proton-Proton Collisions at sqrt[s]=13  TeV.

    Physical review letters·2023
    Same author

    Observation of the Rare Decay of the η Meson to Four Muons.

    Physical review letters·2023
    Same author

    Observation of Same-Sign WW Production from Double Parton Scattering in Proton-Proton Collisions at sqrt[s]=13  TeV.

    Physical review letters·2023
    Same author

    Measurements of jet multiplicity and jet transverse momentum in multijet events in proton-proton collisions at <math></math>.

    The European physical journal. C, Particles and fields·2023

    This study explores the effectiveness of RO 5/4023 in treating hyperkinetic syndromes. The drug demonstrated favorable results, with some cases showing up to 70% improvement in symptoms.

    Area of Science:

    • Neurology
    • Pharmacology

    Context:

    • Investigates the therapeutic applications of RO 5/4023, a drug initiated in 1969.
    • Focuses on hyperkinetic movement disorders, a group of neurological conditions.

    Purpose:

    • To document and evaluate the clinical experiences with RO 5/4023 in patients with hyperkinetic syndromes.
    • To assess the efficacy of RO 5/4023 in managing various movement disorders.

    Summary:

    • The study reviewed therapeutic outcomes for 13 patients across several hyperkinetic syndromes.
    • Conditions treated included facial spasm (6 cases), Huntington disease (3 cases), benign essential tremor (3 cases), and Gilles de La Tourette disease (1 case).
    • Positive therapeutic responses were observed, with efficacy reaching up to 70% in some instances.

    Related Experiment Videos

    Impact:

    • Provides early clinical insights into the potential of RO 5/4023 for hyperkinetic movement disorders.
    • Highlights the drug's favorable results in a diverse patient cohort, suggesting its therapeutic value.